Relevant to obesity, evaluation in mouse models have indicated that the combination of dasatinib and quercetin reduces inflammation, alleviates metabolic dysfunction pre-adiposity, and facilitates the differentiation of adipose cells into mature, insulin-responsive ones (88). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.